S H Kelkar & Company Ltd
S H Kelkar & Company Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Company targets a 12% CAGR growth over the mid to longer term, with recent 9-month performance ahead at nearly 17% YoY growth. - Expectation of reaching around Rs. The company expects to maintain a healthy top-line growth of 12% CAGR over the mid to longer term, with FY25 ahead at ~17%.
From S H Kelkar & Company Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Company targets a 12% CAGR growth over the mid to longer term, with recent 9-month performance ahead at nearly 17% YoY growth.
- Expectation of reaching around Rs. 3,000 crore revenue by FY27, implying approximately 14% CAGR.
- Major growth contribution expected from volume increases rather than price hikes.
- Flavours business anticipated to grow at a strong +15% CAGR, faster than the more mature Fragrance business.
- European business growing healthily at around 12% annually, outpacing the ~2% market average, with potential capacity expansion planned within 1-2 years.
2 more points from S H Kelkar & Company Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what S H Kelkar & Company Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company has completed major investments in development and production capacities for its Flavours business and expects this phase to be finished for the current size.
- Further investments in the Flavours business are anticipated in the next 2 years to support continued growth.
- Recent investments include setting up creative development centers in Europe (UK and Germany) and the USA, focusing on product development teams to serve local and global MNC markets.
- Capital expenditure of around Rs. 75 crore has been incurred for rebuilding a factory after a fire, expected to be reimbursed substantially through insurance.
- The company invested approximately Rs. 45-48 crore in FY25 towards development centers and expects this cost to stabilize and grow only by inflation thereafter.
2 more points from S H Kelkar & Company Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what S H Kelkar & Company Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly mention the exact current or expected order book or pending orders.
- However, the company indicates strong demand and growth prospects despite some slowdown in larger Indian domestic accounts.
- Kedar Vaze highlights a robust 15% year-on-year quarterly growth with no slowdown seen so far.
- The business is gaining market share, especially in new geographies like Southeast Asia, Middle East, Europe, and the US.
- New client engagements and product developments are ongoing, supporting a 12%-14% revenue growth guidance.
2 more points from S H Kelkar & Company Ltd's call on order book
Pro opens every point from 15K+ earnings calls
S H Kelkar & Company Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹650 Cr, net profit ₹2 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What S H Kelkar & Company Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
Others in Chemicals & Petrochemicals this season
- Himadri Special (Q3 FY25)
1,131.81 Crs, up 7.53% YoY (from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- Gujarat Alkalies (Q3 FY25)
3,702.77 Crores (up from Rs. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- Balaji Amines (Q3 FY25)
Q3FY25 consolidated revenue from operations was ₹321 crore, down 18% YoY from ₹392 crore in Q3FY24 (Page 7). Key concall takeaways from Balaji Amines Ltd's Q3…
- Vidhi Specialty Food Ingredients Ltd (Q3 FY25)
Year-on-Year (Y-o-Y) Growth:** 56.5% increase . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY25 earnings call — and how it ranks…
Arthneeti Pro · Annual
S H Kelkar & Company Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were S H Kelkar & Company Ltd Q3 FY25 results?
Company targets a 12% CAGR growth over the mid to longer term, with recent 9-month performance ahead at nearly 17% YoY growth. - Expectation of reaching around Rs. The company expects to maintain a healthy top-line growth of 12% CAGR over the mid to longer term, with FY25 ahead at ~17%.
What is S H Kelkar & Company Ltd share price analysis?
S H Kelkar & Company Ltd currently shows a neutral. The stock trades at a P/E of 50.0 with a market cap of ₹2,363 Cr. Investors should review the full earnings analysis for detailed insights.
Is S H Kelkar & Company Ltd planning capital expenditure?
The company has completed major investments in development and production capacities for its Flavours business and expects this phase to be finished for the current size. - Further investments in the Flavours business are anticipated in the next 2 years to support continued growth. - Recent investments include setting up creative development centers in Europe (UK and Germany) and the USA, focusing on product development teams to serve local and global MNC markets. - Capital expenditure of around Rs.
Keep S H Kelkar & Company Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.